CRO/Sponsor Articles

Real-World Evidence Studies: Methodology Options for Optimal Research

Oct 12, 2015

By Mark Cziraky, Michael Pollock

Essentially, data about real-world patient experience help fill the knowledge gap between clinical trials and actual clinical practice.

Delving into ICON's Use of IBM's Watson

Sep 21, 2015

By Moe Alsumidaie, Lisa Henderson

Steve Cutler, COO, tells Applied Clinical Trials how ICON will be using IBM's Watson Clinical Trial Matching service.

Is a Bigger CRO Better?

Sep 17, 2015

By Jason Monteleone

Much of the growth that has taken place in the top tier of CROs in recent years has been in the acquisition of some of the smaller, more innovative companies, rather than an increase in the number of compounds under study.

Challenges of Clinical Site Management in Eastern Europe and Cross-Regional Prospective

Sep 15, 2015

By Nikolay Grechko, MD, Kateryna Bezditko, PharmD, PhD, Sergii Myronenko, MD

Survey of pharma and CRO clinical trial professionals attempts to answer whether Eastern European countries are still considered attractive destinations for clinical research.

Outsourcing Strategies and Practices to Improve Efficiency and Performance

Aug 11, 2015

By Mary Jo Lamberti, PhD, Frances Grote, Murray A. Abramson, MD, Kenneth A. Getz

Recent studies examining the performance of integrated relationships, in particular, offer mixed results on the impact and satisfaction of these arrangements.

CRO/Sponsor News

PPD Awarded U.S. Army and BARDA Research

In one agreement, the U.S. Army selected PPD to provide health outcomes research for armed services personnel. For the Biomedical Advanced Research and Development Authority (BARDA), PPD will evaluate the potency and long-term stability of H5N1 influenza.

CluePoints, Bracket Join Services for CNS Trials

The companies believe the CluePoints' Central Statistical Monitoring (CSM) solution that uses statistical methodology to identify unusual patterns in clinical trial databases, will help detect potential data quality problems in CNS trials.

INC Research Receives iCardiac Site Certification

With this technology in place, INC may be able to eliminate the need for a separate, dedicated Thorough QT (TQT) studies.

Parexel Becomes SCRS Global Impact Partner

PAREXEL will participate as a Global Impact Partner (GIP) and align with 30 other sponsors, CROs, and service providers dedicated to promoting high-level communication and meaningful collaboration between industry stakeholders and clinical research sites globally

The Prostate Cancer Clinical Trials Consortium Selects WIRB-Copernicus for IRB Services

PCCTC will utilize its services for the review of its cancer research protocols and related study documents.